Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer - Waryah, Charlene (University of Western Australia) ; Cursons, Joseph (Monash University, Australia) ; Foroutan, Momeneh (Department of Biochemistry and Molecular Biology. Monash University, Australia) ; Pflueger, Christian (University of Western Australia) ; Wang, Edina (University of Western Australia) ; Molania, Ramyar (University of Melbourne, Australia) ; Woodward, Eleanor (Harry Perkins Institute of Medical Research, Australia) ; Sorolla, Anabel (University of Western Australia) ; Wallis, Christopher (University of Western Australia) ; Moses, Colette (University of Amsterdam, The Netherlands) ; Glas, Irina (Harry Perkins Institute of Medical Research, Australia) ; Magalhães, Leandro (University of Pará, Brazil) ; Thompson, Erik W. (Queensland University of Technology, Brisbane, Australia) ; Fearnley, Liam G. (University of Melbourne, Australia) ; Chaffer, Christine L. (St Vincent's Clinical School. UNSW Medicine, Australia) ; Davis, Melissa (University of Melbourne, Australia) ; Papenfuss, Anthony T. (University of Melbourne, Australia) ; Redfern, Andrew (University of Western Australia) ; Lister, Ryan (The University of Western Australia) ; Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Blancafort, Pilar (University of Western Australia)
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.